Breaking News, Collaborations & Alliances

Bacthera and Seres Therapeutics Ink Commercial Manufacturing Agreement

Bacthera is establishing a new Microbiome Center of Excellence dedicated at Lonza's site in Visp, Switzerland.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bacthera, a specialized contract development and manufacturing organization (CDMO), and Seres Therapeutics, a microbiome therapeutics company, formed a collaboration to manufacture SER-109, Seres’ lead product candidate for recurrent Clostridioides difficile infection (rCDI). Bacthera is establishing a dedicated facility for commercial manufacturing in its new Microbiome Center of Excellence, a manufacturing site dedicated to the production of LBPs located on Lonza’s Ibex campus in Visp, Switzer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters